Artificial Intelligence & gene therapy to revolutionize human health – Xiaoling Li, Triastek
Xiaoling Li is a Professor of Pharmaceutics and Associate Dean of Graduate Education and Research in Thomas J. Long School of Pharmacy and Health Sciences at the University of the Pacific. He is Co-founder and Chief Scientific Officer, Triastek, Inc., China. Xiaoling Li will speak about Application of 3D Printing Technology in Dosage Form Design and Drug Delivery during the 3D Medical Printing Conference, which will take place on 30-31 January 2018 at MECC Maastricht, The Netherlands.
What drives you?
Innovation, science and technology
What emerging technologies/trends do you see as having the greatest potential in the short and long run?
Artificial Intelligence and gene therapy
What kind of impact do you expect them to have?
Revolutionize the industry and human health
What are the barriers that might stand in the way?
Working on a system with multiple variables.
What do you hope people to learn from your presentation?
3D printing technology will have a significant impact in drug delivery, manufacturing and distribution.